14-3-3ε acts as a proviral factor in highly pathogenic porcine reproductive and respiratory syndrome virus infection

Veterinary Research
Shengliang CaoYihong Xiao

Abstract

The highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) emerged in 2006 in China and caused great economic losses for the swine industry because of the lack of an effective vaccine. 14-3-3 proteins are generating significant interest as potential drug targets by allowing the targeting of specific pathways to elicit therapeutic effects in human diseases. In a previous study, 14-3-3s were identified to interact with non-structural protein 2 (NSP2) of PRRSV. In the present study, the specific subtype 14-3-3ε was confirmed to interact with NSP2 and play a role in the replication of the HP-PRRSV TA-12 strain. Knockdown of 14-3-3ε in Marc-145 cells and porcine alveolar macrophages (PAMs) caused a significant decrease in TA-12 replication, while stable overexpression of 14-3-3ε caused a significant increase in the replication of TA-12 and low pathogenic PRRSV (LP-PRRSV) CH-1R. The 14-3-3 inhibitor difopein also decreased TA-12 and CH-1R replication in Marc-145 cells and PAMs. These findings are consistent with 14-3-3ε acting as a proviral factor and suggest that 14-3-3ε siRNA and difopein are therapeutic candidates against PRRSV infection.

References

Nov 30, 1991·The Veterinary Record·Y ElazharyC Girard
Oct 19, 1991·The Veterinary Record·M Morin, Y Robinson
Jul 1, 1991·The Veterinary Quarterly·G WensvoortF Wagenaar
Oct 13, 2001·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·M J van HemertG P van Heusden
Apr 5, 2005·Journal of Neuropathology and Experimental Neurology·Kristi L HelkeJoseph L Mankowski
Apr 29, 2005·Cell Research·Paulette Mhawech
Aug 11, 2005·Science's STKE : Signal Transduction Knowledge Environment·Dave Bridges, Greg B G Moorhead
May 27, 2006·Seminars in Cancer Biology·Guri TzivionVitaly Balan
Nov 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Xiaowen YangJonathan M Elkins
Feb 7, 2008·Emerging Infectious Diseases·Guang-Zhi TongHua-Ji Qiu
Jul 31, 2008·Aging Cell·Mette Damgaard NielsenHeinrich Jasper
Apr 7, 2009·Methods in Molecular Biology·Kenneth K Wu, Jun-Yang Liou
Nov 10, 2010·Expert Opinion on Therapeutic Targets·Christopher L Neal, Dihua Yu
Jul 20, 2012·Journal of Neurovirology·Diana MoralesSummer F Acevedo
May 16, 2014·Journal of Cancer Research and Clinical Oncology·Yan MaShu-Peng Zhao
Nov 20, 2015·Emerging Infectious Diseases·Lei ZhouHanchun Yang
Mar 22, 2016·Nature Immunology·Ying Kai Chan, Michaela U Gack
Jul 18, 2017·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Ting BianHanchun Yang
Aug 26, 2017·The Open Virology Journal·Kegong Tian
Sep 18, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Andrew KaplanAlyson E Fournier
Mar 10, 2018·Transboundary and Emerging Diseases·H-M WangX-H Cai

❮ Previous
Next ❯

Citations

Aug 20, 2020·Veterinary Research·Shengliang CaoYihong Xiao
Nov 28, 2020·Journal of Hazardous Materials·Shuo ZhangJianzhu Liu
Apr 2, 2021·Journal of Cellular and Molecular Medicine·Jiaqi LiuYihong Xiao
May 24, 2021·Developmental and Comparative Immunology·Xiaoyi PanTing Xu

❮ Previous
Next ❯

Methods Mentioned

BETA
lavage
transfection
PCR
enzyme-linked immunosorbent assays
pull-down
confocal microscopy

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.